Abstract
We read with great interest the article by Hoff et al. on the applicability of visualization of fluorescence in situ hybridization (FISH) probes by dual-color chromogenic in situ hybridization (CISH) and totally agree about the need to perform studies on a larger number of samples to confirm their data. In our laboratory, we have been using this technique for 1 year, and to date our sample is composed of 40 cases tested for HER2/centromere 17 status by FISH and subsequent CISH conversion. In our sample, the concordance between FISH and CISH assays is 100%, in complete agreement with the results reported by Hoff et al. As a matter of fact, as we show in the figure, all pairs of ratio values were consistently above or under the cutoff in every case.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 347-348 |
| Numero di pagine | 2 |
| Rivista | American Journal of Clinical Pathology |
| Volume | 134 |
| Stato di pubblicazione | Pubblicato - 2010 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- breast
- cancer
Fingerprint
Entra nei temi di ricerca di 'CISH the FISH for HER2: our laboratory experience.'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver